American Academy of Physical Medicine and Rehabilitation: “PASC Dashboard”.
Janna Friedly, MD, Executive Director, Post-COVID Rehabilitation and Recovery Clinic, University of Washington.
National Institutes of Health: “Coronavirus Disease 2019 (COVID-19) Treatment Guidelines”, “RECOVER: Researching COVID”, “RECOVER Program takes first steps in advancing clinical trials to better understand long COVID”.
Cancer: “Prevalence and Characteristics of Moderate to Severe Fatigue: A Multicenter Study in Cancer Patients and Survivors.”
National Institute for Health Care and Excellence: “Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy): Diagnosis and Management.”
Monica Verduzco-Gutierrez, MD, Chair of Rehabilitation Medicine, Director, COVID-19 Recovery Clinic, University of Texas Health Science Center at San Antonio.
PM&R: “Multidisciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Fatigue in Postacute Sequelae of SARS-CoV-2 Infection (PASC) Patients.”
The Journal of Head Trauma Rehabilitation: “Efficacy of Amantadine Hydrochloride in Reducing Irritability and Aggression in Chronic Traumatic Brain Injury.”
CNS drugs: “Modafinil: A review of its pharmacology and clinical efficacy in the treatment of narcolepsy.”
Frontiers in Neurology: “Methylphenidate Treatment of Cognitive Dysfunction in Adults After Mild-to-Moderate Traumatic Brain Injury: Rationale, Efficacy, and Neural Mechanisms.”
PM&R: “Multidisciplinary collaborative consensus guidelines for the assessment and management of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC).”
Annals of Clinical and Translational Neurology: “Persistent neurological symptoms and cognitive dysfunction in non-hospitalized long-distance Covid-19 drivers.”
Alba Miranda Azola, MD, Co-Director, Post-Acute COVID-19 Team, Johns Hopkins University School of Medicine, Baltimore.
US National Library of Medicine: “SARS-CoV-2 Viral Persistence Study (PASC) – Study of Long COVID-19.”
PolyBio: “LongCovid Research Consortium”.
Gary H. Gibbons, MD, Director, National Heart, Lung, and Blood Institute.